Catalyst Wire Dossier Catalyst Wire Dossier

Kentera

oxybutynin · Teva B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kentera, covering 2025-04-08 to 2025-04-08. Get the full timeline:

Most recent: EMA Authorised: Kentera (previously Oxybutynin Nicobrand) (oxybutynin) — Teva B.V.

See pricing